Vitamin B Complex & C + 20% Fat Emulsion

Allopathic
Indications

Approved Indications:

  • Total Parenteral Nutrition (TPN): As a component of complete intravenous nutrition in patients unable to eat or absorb nutrients via the gastrointestinal tract.
  • Prevention and treatment of vitamin deficiencies: In hospitalized, post-operative, or critically ill patients with increased metabolic demand.
  • Nutritional support in metabolic stress: Including patients with sepsis, major surgery, trauma, or extensive burns.
  • Malnutrition or cachexia: Especially in cancer, gastrointestinal disorders, or anorexia-related weight loss.
  • Support during refeeding syndrome prevention: To provide essential vitamins and calories in severely malnourished patients.

Clinically Accepted Off-label Uses:

  • Parenteral nutritional support in hepatic/renal impairment: When enteral feeding is not feasible or adequate.
  • Adjunct in chemotherapy/radiotherapy: As nutritional support to improve recovery and immune function.
  • Post-bariatric surgery recovery: Where vitamin absorption is compromised.
Dosage & Administration

Route of Administration: Intravenous infusion only; must be administered under medical supervision as part of a parenteral nutrition regimen.

Adults:

  • Vitamin B Complex (daily average):
    • Thiamine (B1): 3 mg
    • Riboflavin (B2): 3.6 mg
    • Niacinamide (B3): 40 mg
    • Pyridoxine (B6): 4 mg
    • Folic acid (B9): 400 mcg
    • Dexpanthenol (B5): 10 mg
    • Biotin (B7): 60 mcg
    • Cyanocobalamin (B12): 5 mcg
  • Vitamin C: 100–500 mg IV daily, depending on metabolic demand.
  • 20% Fat Emulsion:
    Each 100 mL contains 20 g of fat (soybean oil base).
    Dosage: 1–2 g/kg/day (i.e., 70–140 g fat for a 70 kg adult).
    Infusion rate: Max 0.11 g fat/kg/hour.

Pediatric Dose (under specialist guidance):

  • Vitamin and fat doses adjusted based on age and weight.
  • Fat emulsion: 1–4 g/kg/day depending on caloric need and lipid tolerance.

Elderly:
Same as adult dose, with careful monitoring for hepatic function, lipid clearance, and renal function.

Renal Impairment:

  • Vitamins: No routine dose adjustment required.
  • Fat emulsion: Reduce dose to 0.5–1 g/kg/day in severe cases; monitor fluid and electrolyte status.

Hepatic Impairment:

  • Use with caution.
  • Fat emulsions may accumulate; consider reduced dose and frequent liver function monitoring.

Administration Instructions:

  • Administer via central or large peripheral vein with sterile technique.
  • Combine vitamins and fat emulsion in TPN bag immediately before use.
  • Infusion duration: 8–24 hours depending on clinical need.
  • Discard unused portion after 24 hours.
Mechanism of Action (MOA)

Vitamin B Complex acts as essential coenzymes in various metabolic pathways, including energy production, amino acid metabolism, red blood cell formation, and nervous system maintenance. Vitamin C plays a key role as an antioxidant, supports collagen synthesis, immune function, and enhances iron absorption. The 20% fat emulsion provides long-chain triglycerides (LCTs) as a dense caloric source and essential fatty acids (linoleic and α-linolenic acid) for membrane integrity and prostaglandin synthesis. The combined formulation supports cellular energy, prevents deficiency syndromes, and delivers parenteral calories in patients unable to maintain oral nutrition.

Pharmacokinetics
  • Absorption: 100% bioavailability via IV route; bypasses gastrointestinal tract.
  • Distribution:
    • Water-soluble vitamins (B, C): Rapid distribution in extracellular fluids.
    • Lipid emulsions: Distributed via lipoproteins to adipose and muscle tissue.
  • Metabolism:
    • Vitamins: Metabolized in the liver to active coenzymes.
    • Lipids: Hydrolyzed by lipoprotein lipase into free fatty acids and glycerol.
  • Excretion:
    • Excess vitamins excreted renally.
    • Lipids undergo mitochondrial β-oxidation; minor excretion in bile.
  • Half-life:
    • Vitamin B/C: Short half-lives (hours).
    • Lipid emulsion: ~30–60 minutes plasma half-life; longer in hepatic dysfunction.
Pregnancy Category & Lactation
  • Pregnancy:
    Not assigned formal FDA pregnancy category. However, individual vitamins (B-complex and C) are generally considered safe and essential during pregnancy. Fat emulsions are safe if medically necessary.
    Use under clinical supervision.
  • Lactation:
    Safe when used as part of TPN.
    Water-soluble vitamins are excreted in breast milk in small quantities and are not harmful.
    Fat emulsions have not shown adverse effects on nursing infants.
Therapeutic Class
  • Class: Intravenous Multivitamin and Lipid Emulsion.
  • Subclass: Water-soluble vitamin preparation + parenteral lipid emulsion.
  • Formulation Type: Nutritional supplement for intravenous administration.
Contraindications
  • Known hypersensitivity to soybean oil, egg phospholipids, or any component of the formulation.
  • Severe hyperlipidemia or disorders of fat metabolism.
  • Acute pancreatitis (especially with hyperlipidemia).
  • Severe liver dysfunction or cholestasis.
  • Bleeding disorders (related to lipid component in some cases).
Warnings & Precautions
  • Lipid Overload Syndrome: Monitor serum triglycerides, liver enzymes.
  • Aseptic Technique: Strict asepsis required during mixing and administration.
  • Anaphylaxis Risk: Especially in patients allergic to soy or egg proteins.
  • Monitoring Parameters: Electrolytes, triglycerides, liver function tests, blood glucose, and coagulation profile.
  • Avoid bolus administration. Infuse slowly over 8–24 hours.
  • Use caution in diabetics, renal, hepatic, or critically ill patients.
Side Effects

Common:

  • Nausea, vomiting
  • Mild fever
  • Headache
  • Transient rise in liver enzymes
  • Infusion site irritation

Less Common/Rare:

  • Allergic reactions: rash, bronchospasm, hypotension
  • Lipid overload: hepatomegaly, thrombocytopenia, jaundice
  • Hypertriglyceridemia
  • Fat embolism (extremely rare)

Severity: Mostly mild and reversible; serious events are rare with proper monitoring.

Drug Interactions
  • Warfarin: Vitamin K (in some formulations) may reduce anticoagulant effect.
  • Propofol: Contains lipid; cumulative fat load may increase with concurrent fat emulsion.
  • Heparin: May affect lipid clearance.
  • Corticosteroids/Estrogens: May alter lipid metabolism.
  • Avoid mixing with incompatible IV solutions: Risk of precipitation or emulsion destabilization.
Recent Updates or Guidelines
  • ASPEN & ESPEN Guidelines: Recommend daily multivitamin (including B & C) and lipid emulsion inclusion in all long-term TPN regimens.
  • Fat emulsions: Preference for omega-3 enriched emulsions in critical care per recent ESPEN consensus.
  • WHO/UNICEF Nutritional Guidelines: Reinforce vitamin and essential fatty acid supplementation in malnourished individuals.
  • No recent FDA or EMA label changes noted for this fixed combination.
Storage Conditions
  • Temperature: Store between 2°C to 25°C.
  • Do not freeze. If frozen, discard.
  • Light protection: Protect from direct light; use opaque bags if available.
  • Shake well before use.
  • Shelf life (unopened): 18–24 months.
  • Once mixed or opened: Use within 24 hours.
  • Follow manufacturer’s instructions for storage of compounded TPN bags.